TCM
ARLZ

Tradewinds Capital Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Tradewinds Capital Management’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6
Closed – – 777
2017
Q4 		$0 Hold
6
– – ﹤0.01% 782
2017
Q3 		$0 Hold
6
– – ﹤0.01% 726
2017
Q2 		$0 Hold
6
– – ﹤0.01% 758
2017
Q1 		$0 Hold
6
– – ﹤0.01% 769
2016
Q4 		$0 Hold
6
– – ﹤0.01% 749
2016
Q3 		$0 Sell
6
-1,700
-100% -$7.75K ﹤0.01% 733
2016
Q2 		$6K Buy
+1,706
New +$6.44K ﹤0.01% 433

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BAS
Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return

Tradewinds Capital Management's ARLZ Position: Q1 2018 in Review

Tradewinds Capital Management sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q1 2018, closing a stake of 6 shares.

Tradewinds Capital Management first reported a position in ARLZ in Q2 2016 and held it in 7 quarters. The position peaked at $6K in Q2 2016. 56 funds tracked by Wall St. Rank hold ARLZ as of Q1 2018.

  • Tradewinds Capital Management reported no remaining Aralez Pharmaceuticals Inc. position as of Q1 2018 after selling out during the quarter.
  • Tradewinds Capital Management sold 6 Aralez Pharmaceuticals Inc. shares in Q1 2018.
  • Tradewinds Capital Management first reported a position in Aralez Pharmaceuticals Inc. in Q2 2016 and held it in 7 quarters.
  • Tradewinds Capital Management's Aralez Pharmaceuticals Inc. position peaked at $6K in Q2 2016.
  • 56 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q1 2018.

Based on Tradewinds Capital Management's 13F filing for Q1 2018, filed 2 May 2018.